Back to ELVN
FMR LLC ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
46
Latest value
$89.4M
Q3 2026
Peak value
$449.6M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $69.3M |
| Q1 2023 | $10K |
| Q2 2023 | $81.7M |
| Q2 2023 | $11K |
| Q3 2023 | $50.2M |
| Q3 2023 | $8K |
| Q4 2023 | $64.5M |
| Q4 2023 | $5.4M |
| Q4 2023 | $1.6M |
| Q1 2024 | $98.7M |
| Q1 2024 | $8.1M |
| Q1 2024 | $3.1M |
| Q2 2024 | $115.2M |
| Q2 2024 | $2K |
| Q2 2024 | $13.5M |
| Q2 2024 | $4.3M |
| Q3 2024 | $138.9M |
| Q3 2024 | $16.3M |
| Q3 2024 | $5.6M |
| Q4 2024 | $124.7M |
| Q4 2024 | $16.5M |
| Q4 2024 | $5M |
| Q1 2025 | $108.7M |
| Q1 2025 | $16.5M |
| Q1 2025 | $4.8M |
| Q3 2025 | $142.1M |
| Q3 2025 | $3.4M |
| Q3 2025 | $445K |
| Q4 2025 | $106.6M |
| Q4 2025 | $116 |
| Q4 2025 | $2.6M |
| Q4 2025 | $325K |
| Q1 2026 | $261.1M |
| Q1 2026 | $157 |
| Q1 2026 | $5.8M |
| Q1 2026 | $820K |
| Q2 2026 | $449.6M |
| Q2 2026 | $3.1M |
| Q2 2026 | $376 |
| Q2 2026 | $10.2M |
| Q2 2026 | $45.8M |
| Q3 2026 | $394.2M |
| Q3 2026 | $2.8M |
| Q3 2026 | $138 |
| Q3 2026 | $9.9M |
| Q3 2026 | $89.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $89.4M | 1.95M | — | — |
| Q3 2026 | $9.9M | 216.3K | — | — |
| Q3 2026 | $138 | 3 | — | — |
| Q3 2026 | $2.8M | 61.4K | — | — |
| Q3 2026 | $394.2M | 8.60M | — | — |
| Q2 2026 | $45.8M | 902.7K | — | — |
| Q2 2026 | $10.2M | 201.8K | — | — |
| Q2 2026 | $376 | 7 | — | — |
| Q2 2026 | $3.1M | 61.2K | — | — |
| Q2 2026 | $449.6M | 8.86M | — | — |
| Q1 2026 | $820K | 20.9K | — | — |
| Q1 2026 | $5.8M | 148.3K | — | — |
| Q1 2026 | $157 | 4 | — | — |
| Q1 2026 | $261.1M | 6.66M | — | — |
| Q4 2025 | $325K | 21.1K | — | — |
| Q4 2025 | $2.6M | 167.5K | — | — |
| Q4 2025 | $116 | 8 | — | — |
| Q4 2025 | $106.6M | 6.92M | — | — |
| Q3 2025 | $445K | 21.7K | — | — |
| Q3 2025 | $3.4M | 167.5K | — | — |
| Q3 2025 | $142.1M | 6.94M | — | — |
| Q1 2025 | $4.8M | 244.4K | — | — |
| Q1 2025 | $16.5M | 840.7K | — | — |
| Q1 2025 | $108.7M | 5.52M | — | — |
| Q4 2024 | $5M | 223.6K | — | — |
| Q4 2024 | $16.5M | 731.3K | — | — |
| Q4 2024 | $124.7M | 5.54M | — | — |
| Q3 2024 | $5.6M | 219.1K | — | — |
| Q3 2024 | $16.3M | 636.9K | — | — |
| Q3 2024 | $138.9M | 5.44M | — | — |
| Q2 2024 | $4.3M | 183.7K | — | — |
| Q2 2024 | $13.5M | 579.5K | — | — |
| Q2 2024 | $2K | 77 | — | — |
| Q2 2024 | $115.2M | 4.93M | — | — |
| Q1 2024 | $3.1M | 173.9K | — | — |
| Q1 2024 | $8.1M | 462.0K | — | — |
| Q1 2024 | $98.7M | 5.61M | — | — |
| Q4 2023 | $1.6M | 113.8K | — | — |
| Q4 2023 | $5.4M | 387.3K | — | — |
| Q4 2023 | $64.5M | 4.66M | — | — |
| Q3 2023 | $8K | 556 | — | — |
| Q3 2023 | $50.2M | 3.68M | — | — |
| Q2 2023 | $11K | 556 | — | — |
| Q2 2023 | $81.7M | 4.00M | — | — |
| Q1 2023 | $10K | 456 | — | — |
| Q1 2023 | $69.3M | 3.16M | — | — |
Other funds holding ELVN
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$198.6M
$166.2M